Iterum Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem Nov 30, 2020
UPDATE -- Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020 Oct 19, 2020
Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020 Oct 19, 2020
Iterum Therapeutics Announces Positive Pre-NDA Meeting with FDA for Sulopenem for Treatment of Uncomplicated Urinary Tract Infections Sep 30, 2020
Iterum Therapeutics to Present at the 22nd Annual H.C. Wainwright Global Investment Conference Sep 8, 2020
